ID   FH07
AC   CVCL_E593
SY   FH7; TER317; TER-317; Ter 317; TER391; TER-391; Ter 391; Extract 466
DR   dbMHC; 48847
DR   IHW; IHW09381
DR   IPD-IMGT/HLA; 14085
DR   Wikidata; Q54834795
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/326cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/345cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:06,30:02; B*18:01:01,39:08; C*05:01,07:02; DPA1*01:03; DPB1*02:02,04:02; DQA1*03:01,05:01:01; DQB1*02:01:01,03:02:01; DRB1*03:15,04:07:01; DRB3*02:02:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=14085).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//